Literature DB >> 16629630

Olfactory ensheathing cells: characteristics, genetic engineering, and therapeutic potential.

Marc J Ruitenberg1, Jana Vukovic, Julijana Sarich, Samantha J Busfield, Giles W Plant.   

Abstract

Injured neurons in the mammalian central nervous system (CNS) do not normally regenerate their axons after injury. Neurotrauma to the CNS usually results in axonal damage and subsequent loss of communication between neuronal networks, causing long-term functional deficits. For CNS regeneration, repair strategies need to be developed that promote regrowth of lesioned axon projections and restoration of neuronal connectivity. After spinal cord injury (SCI), cystic cavitations are often found, particularly in the later stages, due to the loss of neural tissue at the original impact site. Ultimately, for the promotion of axonal regrowth in these situations, some form of transplantation will be required to provide lesioned axons with a supportive substrate along which they can extend. Here, we review the use of olfactory ensheathing cells: their location and role in the olfactory system, their use as cellular transplants in SCI paradigms, alone or in combination with gene therapy, and the unique properties of these cells that may give them a potential advantage over other cellular transplants.

Entities:  

Mesh:

Year:  2006        PMID: 16629630     DOI: 10.1089/neu.2006.23.468

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  16 in total

Review 1.  How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?

Authors:  Jia Liu; Hong-Yun Huang
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

Review 2.  Novel combination strategies to repair the injured mammalian spinal cord.

Authors:  Mary Bartlett Bunge
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

Review 3.  Biological roles of olfactory ensheathing cells in facilitating neural regeneration: a systematic review.

Authors:  Hao Yang; Bao-Rong He; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2014-03-11       Impact factor: 5.590

4.  Polymeric scaffolds for three-dimensional culture of nerve cells: a model of peripheral nerve regeneration.

Authors:  Radamés Ayala-Caminero; Luis Pinzón-Herrera; Carol A Rivera Martinez; Jorge Almodovar
Journal:  MRS Commun       Date:  2017-10-03       Impact factor: 2.566

5.  Three-dimensional Collagen Scaffolds in Cultures of Olfactory Ensheathing Cells Used for Severed Spinal Cord Regeneration.

Authors:  Wojciech Fortuna; Benita Wiatrak; Paulina Jawień; Adriana Kubis-Kubiak; Ying Li; Daqing Li; Paweł Tabakow
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 6.  Cell therapy for spinal cord regeneration.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

7.  Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats.

Authors:  Venkata Ramesh Dasari; Daniel G Spomar; Craig Cady; Meena Gujrati; Jasti S Rao; Dzung H Dinh
Journal:  Neurochem Res       Date:  2007-06-13       Impact factor: 3.996

8.  FGF/heparin differentially regulates Schwann cell and olfactory ensheathing cell interactions with astrocytes: a role in astrocytosis.

Authors:  Alessandra Santos-Silva; Richard Fairless; Margaret C Frame; Paul Montague; George M Smith; Andrew Toft; John S Riddell; Susan C Barnett
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

9.  Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.

Authors:  Melissa L M Khoo; Helen Tao; Adrian C B Meedeniya; Alan Mackay-Sim; David D F Ma
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

10.  Calponin is expressed by subpopulations of connective tissue cells but not olfactory ensheathing cells in the neonatal olfactory mucosa.

Authors:  Mercedes Tomé; Edina Siladzic; Alessandra Santos-Silva; Susan C Barnett
Journal:  BMC Neurosci       Date:  2007-09-18       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.